USMJ To Review Twenty-Eight Percent Revenue Growth And 2020 eCommerce Projections Tomorrow
November 25 2019 - 12:57PM
InvestorsHub NewsWire
USMJ To Review Twenty-Eight Percent
Revenue Growth And 2020 eCommerce Projections Tomorrow
Dallas, TX -- November 25, 2019 -- InvestorsHub
NewsWire -- North American Cannabis Holdings, Inc. (USOTC:
USMJ) (“USMJ”) today confirmed a quarterly financial update
scheduled to be published tomorrow, Tuesday, November 26,
2019. USMJ recently published its quarterly financial report
for the period ending September 30, 2019 on the OTC Markets
website. The update tomorrow will review details regarding
the quarterly financial report and projected 2020 growth for the
company’s eCommerce business introduced earlier this
year.
USMJ
reported twenty-eight percent (28%) revenue growth in the fiscal
quarter ending September 30, 2019 compared to the same period in
the previous year. The company’s current annualized revenue
run rate is over a million dollars reporting $287,440 for the
fiscal quarter ending September 30, 2019. The company
reported a net profit of twenty-two (22%) at $62,087.
Management reports that much of the growth comes from USMJ’s new
eCommerce site, www.USMJ.com selling a variety of CBD products and cannabis
essentials. Management plans to release a flurry of
announcements coming soon on the expansion and evolution of USMJ’s
eCommerce business.
Management also indicates that it has identified
a major potential opportunity presented by the prevailing cannabis
sector and has accordingly initiated a plan to seize the
opportunity and that shareholders can expect to hear more about the
initiative before the end of the year. The update next week
will preview early details about the initiative.
To learn more
visit www.USMJ.com
and www.GrowUSMJ.com.
Disclaimer/Safe
Harbor:
This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Steven
Rash
CEO North
American Cannabis Holdings, Inc.
info@aciconglomerated.com
+1-800-861-1350
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Sep 2023 to Sep 2024